Remedy Robotics

Market context

Among the first companies to demonstrate fully remote in-human neurointerventional procedures, advancing surgical robotics toward scalable teleoperated care delivery.

Facts

• Website: https://www.remedyrobotics.com
• HQ: San Francisco, United States
• Founded: 2020
• Segment: Surgical
• Known funding rounds: 1

Funding

• 2025-10-06 - Series A - $35M - Remedy Robotics raises $35M Series A to scale remote surgical robotics platform - source: axios.com

Investors

• Blackbird Ventures - Lead - Vc - 1 funding event - first seen 2025-10-06
• DCVC - Lead - Vc - 1 funding event - first seen 2025-10-06

Remote endovascular surgical robotics company

Remedy Robotics develops a remotely operated endovascular surgical robot for stroke, heart attack and other time-sensitive vascular interventions.

• Target environment: Hospitals, neurointerventional suites, cardiovascular care networks, remote procedure settings and emergency stroke workflows.
• Deployment model: Surgical robot platform development for remote endovascular intervention and specialist access across hospital networks.
• Customer context: Hospitals, interventional physicians, stroke centres, cardiovascular teams and patients needing rapid specialist procedures.
• Workflow context: Remote endovascular intervention, catheter control, neurointervention, cardiovascular procedures and specialist access extension.
• Commercial maturity: Early medical robotics company with public remote procedure milestones and clinical partnership activity.
• Market position: Surgical robotics company focused on remote endovascular intervention rather than general operating-room robotics.
• Adoption constraints: Adoption depends on regulatory clearance, clinical validation, physician training, network latency, hospital integration and reimbursement.
• Adjacent context: Adjacent context includes surgical robotics, remote procedures, endovascular intervention, stroke care and teleoperated medical robots.
• Source confidence: high

Events

• 2025-10-06 - Product Launch - Remedy Robotics Introduces N1 System, Completes First Fully Remote Neurointerventional Procedures - • Remedy Robotics introduced the N1 System, a remotely operable endovascular robotic platform. • Dr. Vitor Mendes Pereira performed the world's first fully remote neurointerventional procedures using the N1 System between St. Michael'... • These procedures we…
• 2025-10-06 - Funding - Remedy Robotics raises $35M Series A to scale remote surgical robotics platform - Remedy Robotics raises $35M Series A to scale remote surgical robotics platform. Named investors or backers include DCVC, Blackbird Ventures. The financing supports continued development, regulatory progress, or deployment of healthcare robotics systems.
• 2025-10-01 - Deployment - Doctors in Toronto complete distant brain angiograms using the N1 system from Remedy Robotics - Remedy Robotics completed the world's first fully remote neurointerventional procedures using the N1 System. Dr. Vitor Mendes Pereira performed these procedures remotely from St. Joseph's Health Centre on patients located at St. Michael's Hospital in Toronto.…

Team

• David Bell - Co-Founder and CEO